EGFR and colorectal carcinoma: However, most CRC display alterations in proto-oncogenes and tumor suppressor genes, leading to the deregulation of a few signaling pathways: WNT/β-catenin, EGFR-RAS-RAF, PI3K, p53, and TGF-β-SMADs [7,8].